Latest News

EADV Scholarships for the EADV Spring Symposium 2025 - Prague, Czech Republic - 22-24 May 2025

We are reaching out to you as, on behalf of the EADV Honours and Awards Committee, chaired by Prof. Asja Prohić, we are pleased to offer several scholarship opportunities.

The Michael Hornstein Memorial Scholarship offers a 1000 EUR travel stipend, a waived registration for the 2025 Spring Symposium, and a complimentary EADV membership for the entire year of 2026. The growth and recognition opportunities that come with these benefits are truly exceptional!

→ This scholarship will be awarded to one successful applicant per country. (If the Committee receives 10 or more eligible applications from the same country, there may be two winners from that country).

The Anchor Drug in Rheumatology: Join Discussion Live: 20th Sept 12.00 - 13.00 BST

Rheumatoid arthritis is an autoinflammatory condition affecting 1% of the adult population, often hallmarked by chronic synovitis. Left untreated it leads to joint pain, swelling and disability. Up to 70% of patients become work-disabled within 5-10 years of symptom onset.

Effective in 50% of early Rheumatoid Arthritis, Methotrexate is one of the first-line disease modifying anti-rheumatic drugs (DMARDs) licensed for treatment. Also used in the treatment of Psoriasis, this revolutionary drug has proven its impact in combination with more advanced therapies such as TNF inhibitors. Response is not, however, universal.

Learning Goals:
How to improve adherence to methotrexate therapy
Which patients experience side effects to methotrexate
What is the impact of immunogenicity on TNF-inhibitor response and how does methotrexate enhance TNF-inhibitor response
 

What questions will be raised in thiswebinar?
What are the barriers to methotrexate adherence?
What are the main side effects patients experience in an observational cohort study?
How does methotrexate affect TNF-inhibitor response?

JOIN THE DISCUSSION LIVE
20th September 2024
12:00-13:00 BST
For more information about our webinars and events, please visit www.aopgbi.org

Upcoming St. John’s DermAcademy Courses

Dear all,

St. John’s DermAcademy is pleased to invite you to join us for our upcoming events. St. John’s DermAcademy is dedicated to providing high-quality, evidence-based dermatology education, designed and delivered by leading clinicians and academics from St. John's Institute of Dermatology, along with distinguished invited speakers.

We are also excited to announce our latest podcasts episodes where our host Dr Sarah Drummond discusses Immunobullous Disorders with Dr Thomas Tull and explores Eczema Therapeutics with Professor Catherine Smith and Dr Andrew Pink.

For further information please visit https://www.stjohnsdermacademy.com/. We look forward to welcoming  you at our future events.

Best wishes,

Dr Leonard Timoney
Senior Clinical Fellow in Medical Dermatology and Medical Education

On behalf of St John’s DermAcademy